Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) ...
FDA Recall #D-0467-2024 — Class III — April 9, 2024
Product Description
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.
Reason for Recall
Cross Contamination with Other Products
Recalling Firm
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. — Tokushima, N/A
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Product Quantity
N/A
Distribution
USA nationwide.
Code Information
Lot #: a) ALS00422A, Exp 04/30/2025; ALS00523A, Exp 11/30/2025; b) 1K77YUD1H1A, Exp 11/30/2024
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated